A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

ClinicalTrials.gov ID: NCT07088926

Public ClinicalTrials.gov record NCT07088926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 3:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb Randomized, Double-blind, Placebo-controlled, Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Study identification

NCT ID: NCT07088926
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: AstraZeneca; Industry
Enrollment: 435 participants

Conditions and interventions

Conditions

Bronchiectasis With Pseudomonas Aeruginosa Colonization

Interventions

AZD0292 Biological
Placebo Other

Biological · Other

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 5, 2025
Primary completion: Dec 8, 2027
Completion: Jun 13, 2028
Last update posted: May 6, 2026

2025 – 2028

United States locations

U.S. sites: 24
U.S. states: 15
U.S. cities: 24

Facility	City	State	ZIP	Site status
Research Site	Orange	California	92868	Not yet recruiting
Research Site	San Francisco	California	94143	Recruiting
Research Site	Denver	Colorado	80206	Not yet recruiting
Research Site	Washington D.C.	District of Columbia	20007	Recruiting
Research Site	Jacksonville	Florida	32209	Recruiting
Research Site	Miami Lakes	Florida	33014	Suspended
Research Site	Naples	Florida	34102	Recruiting
Research Site	Ormond Beach	Florida	32174	Recruiting
Research Site	Plantation	Florida	33324	Recruiting
Research Site	Rincon	Georgia	31326	Recruiting
Research Site	Kansas City	Kansas	66160	Recruiting
Research Site	Ann Arbor	Michigan	48109	Not yet recruiting
Research Site	Rochester	Minnesota	55905	Withdrawn
Research Site	St Louis	Missouri	63130	Recruiting
Research Site	New York	New York	10016	Recruiting
Research Site	New Bern	North Carolina	28562	Not yet recruiting
Research Site	Winston-Salem	North Carolina	27104	Not yet recruiting
Research Site	Tulsa	Oklahoma	74133	Withdrawn
Research Site	DuBois	Pennsylvania	15801	Withdrawn
Research Site	Philadelphia	Pennsylvania	19104	Not yet recruiting
Research Site	Charleston	South Carolina	29425	Not yet recruiting
Research Site	Rock Hill	South Carolina	29732	Recruiting
Research Site	Austin	Texas	78705	Withdrawn
Research Site	Mansfield	Texas	76063	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 159 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07088926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 6, 2026 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07088926 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →